545 related articles for article (PubMed ID: 29341118)
1. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.
Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N
Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118
[TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
4. Residual LCMV antigen in transiently CD4
Schweier O; Aichele U; Marx AF; Straub T; Verbeek JS; Pinschewer DD; Pircher H
Eur J Immunol; 2019 Apr; 49(4):626-637. PubMed ID: 30636035
[TBL] [Abstract][Full Text] [Related]
5. Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.
Richter K; Oxenius A
Eur J Immunol; 2013 Sep; 43(9):2349-60. PubMed ID: 23749374
[TBL] [Abstract][Full Text] [Related]
6. Interrogating Adaptive Immunity Using LCMV.
Dangi T; Chung YR; Palacio N; Penaloza-MacMaster P
Curr Protoc Immunol; 2020 Sep; 130(1):e99. PubMed ID: 32940427
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
8. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
[TBL] [Abstract][Full Text] [Related]
9. IRF9 Prevents CD8
Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
[TBL] [Abstract][Full Text] [Related]
10. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
11. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659
[TBL] [Abstract][Full Text] [Related]
12. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
Suresh M; Gao X; Fischer C; Miller NE; Tewari K
J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
[TBL] [Abstract][Full Text] [Related]
14. Vectored antibody gene delivery restores host B and T cell control of persistent viral infection.
Ertuna YI; Fallet B; Marx AF; Dimitrova M; Kastner AL; Wagner I; Merkler D; Pinschewer DD
Cell Rep; 2021 Nov; 37(9):110061. PubMed ID: 34852228
[TBL] [Abstract][Full Text] [Related]
15. Enhancing immunity prevents virus-induced T-cell-mediated immunopathology in B cell-deficient mice.
Straub T; Pircher H
Eur J Immunol; 2019 May; 49(5):782-789. PubMed ID: 30793761
[TBL] [Abstract][Full Text] [Related]
16. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
[TBL] [Abstract][Full Text] [Related]
17. Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells.
Matter MS; Hilmenyuk T; Claus C; Marone R; Schürch C; Tinguely M; Terracciano L; Luther SA; Ochsenbein AF
PLoS One; 2011; 6(9):e24772. PubMed ID: 21966366
[TBL] [Abstract][Full Text] [Related]
18. T-cell STAT3 is required for the maintenance of humoral immunity to LCMV.
McIlwain DR; Grusdat M; Pozdeev VI; Xu HC; Shinde P; Reardon C; Hao Z; Beyer M; Bergthaler A; Häussinger D; Nolan GP; Lang KS; Lang PA
Eur J Immunol; 2015 Feb; 45(2):418-27. PubMed ID: 25393615
[TBL] [Abstract][Full Text] [Related]
19. Mast Cells Modulate Antigen-Specific CD8
Hackler Y; Siebenhaar F; Löhning M; Maurer M; Muñoz M
Front Immunol; 2021; 12():688347. PubMed ID: 34194439
[TBL] [Abstract][Full Text] [Related]
20. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
